Hit validation is a critical step in the drug discovery process, particularly in cancer research. It involves confirming that a particular compound, identified during initial screening, has a genuine and reproducible effect on a biological target involved in cancer progression. This step ensures that the initial "hits" from high-throughput screening are not false positives and are worth further investigation.